SCHEMBL5782306

SCHEMBL5782306

O=C(c1ccccc1F)N1c2ccc(F)cc2C2(CCNCC2)[C@H]1CC1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MAPK14 Q16539 1/20 0.35
SMYD3 Q9H7B4 2/20 0.35
HSD11B1 P28845 1/20 0.35
GNRHR P30968 1/20 0.34
KCNH2 Q12809 1/20 0.34
HTT P42858 1/20 0.33
PAX8 Q06710 1/20 0.33
LMNA P02545 1/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
DPP4 P27487 1/20 0.33
NPY5R Q15761 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5600002 0.93 P2RX7 (0.37) HTR2AHTR2CCYP2C19GNRHRKCNH2
SCHEMBL5783985 0.92 DPP4 (0.34) HTR2AHTR2CGNRHRKCNH2DPP4
SCHEMBL5599358 0.92 PARP1 (0.36) GNRHRKCNH2DPP4PSEN1PSEN2
SCHEMBL5599374 0.91 GNRHR (0.40) CYP2C9CYP2C19MAPK14HSD11B1GNRHR
SCHEMBL5599389 0.91 GNRHR (0.40) CYP2C9CYP2C19MAPK14HSD11B1GNRHR
SCHEMBL5782925 0.89 LMNA (0.39) CYP2C9CYP2C19MAPK14HSD11B1HTT
SCHEMBL5599710 0.86 GLA (0.37) GNRHRKCNH2HTTLMNANR3C2
SCHEMBL5599242 0.85 CYP3A4 (0.38) CYP2C9CYP2C19HSD11B1GNRHRKCNH2
SCHEMBL5783469 0.83 ALDH1A1 (0.47) CYP2C9SMYD3GNRHRKCNH2LMNA
SCHEMBL5784243 0.83 GNRHR (0.42) HTR2AHTR2CSMYD3HSD11B1GNRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1716148-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF Arena Pharmaceuticals, Inc. (US) 2006-11-02 EP claimed
WO-2005063745-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARMACEUTICALS, INC. (US) 2005-07-14 WO claimed